Radiotherapy or chemoradiotherapy for postoperative locoregional recurrence of non-small cell lung cancer

Kei Shibuya*, J. Saito, T. Kazumoto, Y. Saito, H. Nishimura, H. Akiyama, S. Kato

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Twenty-two patients with locoregional recurrent non-small cell lung cancer after surgical resection. RT doses that ranged from 50 to 67 Gy were delivered. Chemotherapy was performed concurrently in twelve patients. The overall 2-year and 3-year survival rates after treatment for recurrences were 46% and 31%. The median survival time was 15.6 months. No severe acute and late toxicity was observed. In conclusion, radiotherapy or chemoradiationtherapy for postsurgical locoregional recurrences is an effective and safe treatment modality.

Original languageEnglish
Pages (from-to)182-187
Number of pages6
JournalJapanese Journal of Clinical Radiology
Volume54
Issue number1
StatePublished - 2009

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Radiotherapy or chemoradiotherapy for postoperative locoregional recurrence of non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this